Report Detail
Global Anti-obesity Medicine Market Opportunities and Forecast 2022-2028
- RnM4401102 |
- 22 March, 2022 |
- Global |
- 161 Pages |
- GRD Survey |
- Pharma & Healthcare
This report provides a comprehensive analysis of current global Anti-obesity Medicine market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Anti-obesity Medicine industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.
According to this survey, the global Anti-obesity Medicine market is estimated at $ 1950 million in 2021, and projected to grow at a CAGR of 18.8% to $ 6510 million by 2028.
Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Anti-obesity Medicine Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Anti-obesity Medicine market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.
The Global Anti-obesity Medicine Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Anti-obesity Medicine industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions
Segmented by Type
Prescription Drugs
OTC Drugs
Segmented by Application
Men
Women
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Pfizer
Orexigen Therapeutics
Novo Nordisk
Merck
GlaxoSmithKline
Eisai
Boehringer Ingelheim
Arena Pharmaceuticals
Amylin Pharmaceuticals
Alizyme
Table of Contents
1 Product Introduction and Overview
- 1.1 Product Definition
- 1.2 Product Specification
- 1.3 Global Market Overview
- 1.3.1 Global Anti-obesity Medicine Market Status and Forecast (2017-2028)
- 1.3.2 Global Anti-obesity Medicine Sales Value CAGR by Region
- 1.4 Market Drivers, Inhibitors
- 1.4.1 Market Drivers
- 1.4.2 Market Inhibitors
- 1.4.3 COVID-19 Impact Analysis
2 Global Anti-obesity Medicine Supply by Company
- 2.1 Global Anti-obesity Medicine Sales Volume by Company
- 2.2 Global Anti-obesity Medicine Sales Value by Company
- 2.3 Global Anti-obesity Medicine Price by Company
- 2.4 Anti-obesity Medicine Production Location and Sales Area of Main Manufacturers
- 2.5 Trend of Concentration Rate
3 Global and Regional Anti-obesity Medicine Market Status by Type
- 3.1 Anti-obesity Medicine Type Introduction
- 3.1.1 Prescription Drugs
- 3.1.2 OTC Drugs
- 3.2 Global Anti-obesity Medicine Market by Type
- 3.2.1 Global Anti-obesity Medicine Sales Volume by Type (2017-2022)
- 3.2.2 Global Anti-obesity Medicine Sales Value by Type (2017-2022)
- 3.2.3 Global Anti-obesity Medicine Price by Type (2017-2022)
- 3.3 North America: by Type
- 3.4 Europe: by Type
- 3.5 Asia Pacific: by Type
- 3.6 Central & South America: by Type
- 3.7 Middle East & Africa: by Type
4 Global and Regional Anti-obesity Medicine Market Status by Application
- 4.1 Anti-obesity Medicine Segment by Application
- 4.1.1 Men
- 4.1.2 Women
- 4.2 Global Anti-obesity Medicine Market by Application
- 4.2.1 Global Anti-obesity Medicine Sales Volume by Application (2017-2022)
- 4.2.2 Global Anti-obesity Medicine Sales Value by Application (2017-2022)
- 4.2.3 Global Anti-obesity Medicine Price by Application (2017-2022)
- 4.3 North America: by Application
- 4.4 Europe: by Application
- 4.5 Asia Pacific: by Application
- 4.6 Central & South America: by Application
- 4.7 Middle East & Africa: by Application
5 Global Anti-obesity Medicine Market Status by Region
- 5.1 Global Anti-obesity Medicine Market by Region
- 5.1.1 Global Anti-obesity Medicine Sales Volume by Region
- 5.1.2 Global Anti-obesity Medicine Sales Value by Region
- 5.2 North America Anti-obesity Medicine Market Status
- 5.3 Europe Anti-obesity Medicine Market Status
- 5.4 Asia Pacific Anti-obesity Medicine Market Status
- 5.5 Central & South America Anti-obesity Medicine Market Status
- 5.6 Middle East & Africa Anti-obesity Medicine Market Status
6 North America Anti-obesity Medicine Market Status
- 6.1 North America Anti-obesity Medicine Market by Country
- 6.1.1 North America Anti-obesity Medicine Sales Volume by Country (2017-2022)
- 6.1.2 North America Anti-obesity Medicine Sales Value by Country (2017-2022)
- 6.2 United States
- 6.3 Canada
- 6.4 Mexico
7 Europe Anti-obesity Medicine Market Status
- 7.1 Europe Anti-obesity Medicine Market by Country
- 7.1.1 Europe Anti-obesity Medicine Sales Volume by Country (2017-2022)
- 7.1.2 Europe Anti-obesity Medicine Sales Value by Country (2017-2022)
- 7.2 Germany
- 7.3 France
- 7.4 UK
- 7.5 Italy
- 7.6 Russia
- 7.7 Spain
8 Asia Pacific Anti-obesity Medicine Market Status
- 8.1 Asia Pacific Anti-obesity Medicine Market by Country
- 8.1.1 Asia Pacific Anti-obesity Medicine Sales Volume by Country (2017-2022)
- 8.1.2 Asia Pacific Anti-obesity Medicine Sales Value by Country (2017-2022)
- 8.2 China
- 8.3 Japan
- 8.4 Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australasia
9 Central & South America Anti-obesity Medicine Market Status
- 9.1 Central & South America Anti-obesity Medicine Market by Country
- 9.1.1 Central & South America Anti-obesity Medicine Sales Volume by Country (2017-2022)
- 9.1.2 Central & South America Anti-obesity Medicine Sales Value by Country (2017-2022)
- 9.2 Brazil
- 9.3 Argentina
- 9.4 Colombia
10 Middle East & Africa Anti-obesity Medicine Market Status
- 10.1 Middle East & Africa Anti-obesity Medicine Market by Country
- 10.1.1 Middle East & Africa Anti-obesity Medicine Sales Volume by Country (2017-2022)
- 10.1.2 Middle East & Africa Anti-obesity Medicine Sales Value by Country (2017-2022)
- 10.2 Iran
- 10.3 Israel
- 10.4 Turkey
- 10.5 South Africa
- 10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
- 11.1 Supply Chain Analysis
- 11.2 Production Process Chart Analysis
- 11.3 Raw Materials and Key Suppliers Analysis
- 11.3.1 Raw Materials Introduction
- 11.3.2 Raw Materials Key Suppliers List
- 11.4 Anti-obesity Medicine Manufacturing Cost Analysis
- 11.5 Anti-obesity Medicine Sales Channel and Distributors Analysis
- 11.5.1 Anti-obesity Medicine Sales Channel
- 11.5.2 Anti-obesity Medicine Distributors
- 11.6 Anti-obesity Medicine Downstream Major Buyers
12 Global Anti-obesity Medicine Market Forecast by Type and by Application
- 12.1 Global Anti-obesity Medicine Sales Volume and Sales Value Forecast (2023-2028)
- 12.2 Global Anti-obesity Medicine Forecast by Type
- 12.2.1 Global Anti-obesity Medicine Sales Volume Forecast by Type
- 12.2.2 Global Anti-obesity Medicine Sales Value Forecast by Type
- 12.2.3 Global Anti-obesity Medicine Price Forecast by Type
- 12.3 Global Anti-obesity Medicine Forecast by Application
- 12.3.1 Global Anti-obesity Medicine Sales Volume Forecast by Application
- 12.3.2 Global Anti-obesity Medicine Sales Value Forecast by Application
- 12.3.3 Global Anti-obesity Medicine Price Forecast by Application
13 Global Anti-obesity Medicine Market Forecast by Region/Country
- 13.1 Global Anti-obesity Medicine Market Forecast by Region (2023-2028)
- 13.1.1 Global Anti-obesity Medicine Sales Volume Forecast by Region (2023-2028)
- 13.1.2 Global Anti-obesity Medicine Sales Value Forecast by Region (2023-2028)
- 13.2 North America Market Forecast
- 13.3 Europe Market Forecast
- 13.4 Asia Pacific Market Forecast
- 13.5 Central & South America Market Forecast
- 13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
- 14.1 Vivus
- 14.1.1 Company Information
- 14.1.2 Anti-obesity Medicine Product Introduction
- 14.1.3 Vivus Anti-obesity Medicine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.1.4 SWOT Analysis
- 14.2 Roche
- 14.2.1 Company Information
- 14.2.2 Anti-obesity Medicine Product Introduction
- 14.2.3 Roche Anti-obesity Medicine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.2.4 SWOT Analysis
- 14.3 Pfizer
- 14.3.1 Company Information
- 14.3.2 Anti-obesity Medicine Product Introduction
- 14.3.3 Pfizer Anti-obesity Medicine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.3.4 SWOT Analysis
- 14.4 Orexigen Therapeutics
- 14.4.1 Company Information
- 14.4.2 Anti-obesity Medicine Product Introduction
- 14.4.3 Orexigen Therapeutics Anti-obesity Medicine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.4.4 SWOT Analysis
- 14.5 Novo Nordisk
- 14.5.1 Company Information
- 14.5.2 Anti-obesity Medicine Product Introduction
- 14.5.3 Novo Nordisk Anti-obesity Medicine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.5.4 SWOT Analysis
- 14.6 Merck
- 14.6.1 Company Information
- 14.6.2 Anti-obesity Medicine Product Introduction
- 14.6.3 Merck Anti-obesity Medicine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.6.4 SWOT Analysis
- 14.7 GlaxoSmithKline
- 14.7.1 Company Information
- 14.7.2 Anti-obesity Medicine Product Introduction
- 14.7.3 GlaxoSmithKline Anti-obesity Medicine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.7.4 SWOT Analysis
- 14.8 Eisai
- 14.8.1 Company Information
- 14.8.2 Anti-obesity Medicine Product Introduction
- 14.8.3 Eisai Anti-obesity Medicine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.8.4 SWOT Analysis
- 14.9 Boehringer Ingelheim
- 14.9.1 Company Information
- 14.9.2 Anti-obesity Medicine Product Introduction
- 14.9.3 Boehringer Ingelheim Anti-obesity Medicine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.9.4 SWOT Analysis
- 14.10 Arena Pharmaceuticals
- 14.10.1 Company Information
- 14.10.2 Anti-obesity Medicine Product Introduction
- 14.10.3 Arena Pharmaceuticals Anti-obesity Medicine Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.10.4 SWOT Analysis
- 14.11 Amylin Pharmaceuticals
- 14.12 Alizyme
15 Conclusion
16 Methodology
Summary:
Get latest Market Research Reports on Anti-obesity Medicine. Industry analysis & Market Report on Anti-obesity Medicine is a syndicated market report, published as Global Anti-obesity Medicine Market Opportunities and Forecast 2022-2028. It is complete Research Study and Industry Analysis of Anti-obesity Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
